These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 38659022)
1. Understanding the matrix: collagen modifications in tumors and their implications for immunotherapy. Borst R; Meyaard L; Pascoal Ramos MI J Transl Med; 2024 Apr; 22(1):382. PubMed ID: 38659022 [TBL] [Abstract][Full Text] [Related]
2. Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix. Flies DB; Langermann S; Jensen C; Karsdal MA; Willumsen N Front Immunol; 2023; 14():1199513. PubMed ID: 37662958 [TBL] [Abstract][Full Text] [Related]
3. Immune Modulatory Properties of Collagen in Cancer. Rømer AMA; Thorseth ML; Madsen DH Front Immunol; 2021; 12():791453. PubMed ID: 34956223 [TBL] [Abstract][Full Text] [Related]
4. Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy. Mai Z; Lin Y; Lin P; Zhao X; Cui L Cell Death Dis; 2024 May; 15(5):307. PubMed ID: 38693104 [TBL] [Abstract][Full Text] [Related]
5. Extracellular matrix stiffness and tumor-associated macrophage polarization: new fields affecting immune exclusion. Yu KX; Yuan WJ; Wang HZ; Li YX Cancer Immunol Immunother; 2024 May; 73(6):115. PubMed ID: 38693304 [TBL] [Abstract][Full Text] [Related]
6. The extracellular matrix in solid tumor immunotherapy. Cho Y; Doh J Trends Immunol; 2024 Sep; 45(9):705-714. PubMed ID: 39164157 [TBL] [Abstract][Full Text] [Related]
7. Collagen Fragments Produced in Cancer Mediate T Cell Suppression Through Leukocyte-Associated Immunoglobulin-Like Receptor 1. Vijver SV; Singh A; Mommers-Elshof ETAM; Meeldijk J; Copeland R; Boon L; Langermann S; Flies D; Meyaard L; Ramos MIP Front Immunol; 2021; 12():733561. PubMed ID: 34691040 [TBL] [Abstract][Full Text] [Related]
8. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. Yuan Z; Li Y; Zhang S; Wang X; Dou H; Yu X; Zhang Z; Yang S; Xiao M Mol Cancer; 2023 Mar; 22(1):48. PubMed ID: 36906534 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of Extracellular Matrix Composition to Improve Breast Cancer Modeling. Byrne CE; Decombe JB; Bingham GC; Remont J; Miller LG; Khalif L; King CT; Hamel K; Bunnell BA; Burow ME; Martin EC Tissue Eng Part A; 2021 Apr; 27(7-8):500-511. PubMed ID: 33797977 [TBL] [Abstract][Full Text] [Related]
10. Crosstalk between T lymphocyte and extracellular matrix in tumor microenvironment. Lv D; Fei Y; Chen H; Wang J; Han W; Cui B; Feng Y; Zhang P; Chen J Front Immunol; 2024; 15():1340702. PubMed ID: 38690275 [TBL] [Abstract][Full Text] [Related]
11. Biological role of matrix stiffness in tumor growth and treatment. Deng B; Zhao Z; Kong W; Han C; Shen X; Zhou C J Transl Med; 2022 Nov; 20(1):540. PubMed ID: 36419159 [TBL] [Abstract][Full Text] [Related]
12. Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment. Nicolas-Boluda A; Vaquero J; Vimeux L; Guilbert T; Barrin S; Kantari-Mimoun C; Ponzo M; Renault G; Deptula P; Pogoda K; Bucki R; Cascone I; Courty J; Fouassier L; Gazeau F; Donnadieu E Elife; 2021 Jun; 10():. PubMed ID: 34106045 [TBL] [Abstract][Full Text] [Related]
13. Passing the post: roles of posttranslational modifications in the form and function of extracellular matrix. Adams JC Am J Physiol Cell Physiol; 2023 May; 324(5):C1179-C1197. PubMed ID: 36912485 [TBL] [Abstract][Full Text] [Related]
15. Cell-ECM Interactions in Tumor Invasion. He X; Lee B; Jiang Y Adv Exp Med Biol; 2016; 936():73-91. PubMed ID: 27739043 [TBL] [Abstract][Full Text] [Related]
17. Towards extracellular matrix normalization for improved treatment of solid tumors. Abyaneh HS; Regenold M; McKee TD; Allen C; Gauthier MA Theranostics; 2020; 10(4):1960-1980. PubMed ID: 32042347 [TBL] [Abstract][Full Text] [Related]
18. Post-translational modifications of the extracellular matrix are key events in cancer progression: opportunities for biochemical marker development. Leeming DJ; Bay-Jensen AC; Vassiliadis E; Larsen MR; Henriksen K; Karsdal MA Biomarkers; 2011 May; 16(3):193-205. PubMed ID: 21506694 [TBL] [Abstract][Full Text] [Related]
19. High-Throughput Microfluidic 3D Cytotoxicity Assay for Cancer Immunotherapy (CACI-IMPACT Platform). Park D; Son K; Hwang Y; Ko J; Lee Y; Doh J; Jeon NL Front Immunol; 2019; 10():1133. PubMed ID: 31191524 [TBL] [Abstract][Full Text] [Related]
20. A complex interplay between the extracellular matrix and the innate immune response to microbial pathogens. Tomlin H; Piccinini AM Immunology; 2018 Oct; 155(2):186-201. PubMed ID: 29908065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]